Low‐dose and long‐term azithromycin significantly decreases <i>Staphylococcus aureus</i> in the microbiome of refractory CRS patients

Axel E. Renteria(Centre Hospitalier de l’Université de Montréal), Martin Desrosiers(Centre Hospitalier de l’Université de Montréal), Marc‐Henri Asmar(Centre Hospitalier de l’Université de Montréal), Anastasios Maniakas(The University of Texas MD Anderson Cancer Center), Leandra Endam Mfuna(Centre Hospitalier de l’Université de Montréal), Emmanuel González(Inserm)
International Forum of Allergy & Rhinology
July 26, 2020
10.1002/alr.22653
Cited by 18

Related Papers

EUFOREA consensus on biologics for CRSwNP with or without asthma
|Allergy|2019|378
Altered microbiome composition in individuals with fibromyalgia
|Pain|2019|218
Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines
|Gut|2022|113
Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation
|ChemMedChem|2011|105
The Response of a 16S Ribosomal RNA Gene Fragment Amplified Community to Lead, Zinc, and Copper Pollution in a Shanghai Field Trial
|Frontiers in Microbiology|2018|88